Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

Clinical trial NCT00240344 · COMPLETED

Trial details

NCT number: NCT00240344
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Hypercholesterolemia

Start date: 2004-09-01
Primary completion: 2008-02-01
Enrollment: 2650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.